Skip to Content

Dysport Approval History

  • FDA approved: Yes (First approved April 29th, 2009)
  • Brand name: Dysport
  • Generic name: abobotulinumtoxinA
  • Company: Medicis and Ipsen
  • Treatment for: Cervical Dystonia, Facial Wrinkles

Dysport (abobotulinumtoxinA) is an acetylcholine release inhibitor and a neuromuscular blocking agent for the treatment of cervical dystonia in adults to reduce the severity of abnormal head position and neck pain, and for the temporary improvement in the appearance of moderate to severe glabellar lines.

FDA Approval History for Dysport

Apr 30, 2009Approval FDA Approves Dysport for Therapeutic and Aesthetic Uses
Dec 29, 2008FDA Issues Complete Response Letter to Ipsen for Dysport Biologics License Application
Jan 31, 2008Ipsen: FDA Accepts for Filing a Biologics License Application (BLA) for Dysport in Cervical Dystonia
Dec  6, 2007Ipsen Submits a Biologics License Application in Cervical Dystonia to the FDA for Dysport

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.